BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22898315)

  • 1. Re-induction of cell differentiation and (131)I uptake in dedifferentiated FTC-133 cell line by TSHR gene transfection.
    Feng F; Wang H; Hou S; Fu H
    Nucl Med Biol; 2012 Nov; 39(8):1261-5. PubMed ID: 22898315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of lentiviral-mediated transfection of hTSHR in poorly differentiated thyroid carcinoma cell line.
    Cheng W; Fu H; Feng F; Ma C; Li J; Chen S; Wang H
    Nucl Med Biol; 2013 May; 40(4):576-80. PubMed ID: 23618770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dedifferentiation of differentiated thyroid carcinoma cell line FTC-133 is enhanced by 131I pretreatment.
    Feng F; Wang H; Fu H; Wu S; Ye Z; Chen S; Li J
    Nucl Med Biol; 2011 Oct; 38(7):1053-8. PubMed ID: 21982575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid and tributyrin induce in-vitro radioiodine uptake and inhibition of cell proliferation in a poorly differentiated follicular thyroid carcinoma.
    Zhang M; Guo R; Xu H; Zhang M; Li B
    Nucl Med Commun; 2011 Jul; 32(7):605-10. PubMed ID: 21471848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different expression of TSH receptor and NIS genes in thyroid cancer: role of epigenetics.
    D'Agostino M; Sponziello M; Puppin C; Celano M; Maggisano V; Baldan F; Biffoni M; Bulotta S; Durante C; Filetti S; Damante G; Russo D
    J Mol Endocrinol; 2014 Apr; 52(2):121-31. PubMed ID: 24353283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transfection of follicular thyroid gland carcinoma cells with human TSH receptor changes growth, invasion and adhesion].
    Hoelting T; Duh QY; Clark OH; Herfarth C
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):281-4. PubMed ID: 14518260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression of differentiation- and dedifferentiation markers in normal and malignant human thyroid tissues.
    Hoang-Vu C; Dralle H; Scheumann G; Maenhaut C; Horn R; von zur Mühlen A; Brabant G
    Exp Clin Endocrinol; 1992; 100(1-2):51-6. PubMed ID: 1281780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies.
    Liu YY; van der Pluijm G; Karperien M; Stokkel MP; Pereira AM; Morreau J; Kievit J; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):617-24. PubMed ID: 16712662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncofoetal fibronectin--a tumour-specific marker in detecting minimal residual disease in differentiated thyroid carcinoma.
    Hesse E; Musholt PB; Potter E; Petrich T; Wehmeier M; von Wasielewski R; Lichtinghagen R; Musholt TJ
    Br J Cancer; 2005 Sep; 93(5):565-70. PubMed ID: 16091757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptake.
    Tuncel M; Aydin D; Yaman E; Tazebay UH; Güç D; Doğan AL; Taşbasan B; Uğur O
    Cancer Biother Radiopharm; 2007 Jun; 22(3):443-9. PubMed ID: 17679169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptake.
    Tuncel M; Aydin D; Yaman E; Tazebay UH; Güç D; Doğan AL; Taşbasan B; Uğur O
    Cancer Biother Radiopharm; 2007 Apr; 22(2):281-8. PubMed ID: 17600477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery of NIS expression in thyroid cancer cells by overexpression of Pax8 gene.
    Presta I; Arturi F; Ferretti E; Mattei T; Scarpelli D; Tosi E; Scipioni A; Celano M; Gulino A; Filetti S; Russo D
    BMC Cancer; 2005 Jul; 5():80. PubMed ID: 16029487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cotransfected sodium iodide symporter and human tyroperoxidase genes following human telomerase reverse transcriptase promoter for targeted radioiodine therapy of malignant glioma cells.
    Li W; Tan J; Wang P; Wu P
    Cancer Biother Radiopharm; 2011 Aug; 26(4):443-51. PubMed ID: 21797672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of iodide uptake and efflux in various human thyroid cancer cells by expressing sodium iodide symporter gene via a recombinant adenovirus.
    Lee WW; Lee B; Kim SJ; Jin J; Moon DH; Lee H
    Oncol Rep; 2003; 10(4):845-9. PubMed ID: 12792733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood thyroglobulin and TSH receptor mRNA detection by RT-PCR in the follow-up of differentiated thyroid cancer patients.
    Torosian L; Manrique G; Alvarez B; Lago G; Roca R; Belzarena C
    Rev Esp Med Nucl; 2010; 29(3):109-13. PubMed ID: 20399540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer.
    Milas M; Barbosa GF; Mitchell J; Berber E; Siperstein A; Gupta M
    Ann Surg Oncol; 2009 Feb; 16(2):473-80. PubMed ID: 19015922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin enhances the membrane trafficking of the sodium iodide symporter and augments radioiodine uptake in dedifferentiated thyroid cancer cells
    Zhang L; Xu S; Cheng X; Wu J; Wang X; Wu L; Yu H; Bao J
    Food Funct; 2021 Sep; 12(18):8260-8273. PubMed ID: 34323243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional thyrotropin receptor attenuates malignant phenotype of follicular thyroid cancer cells.
    Hoffmann S; Maschuw K; Hassan I; Wunderlich A; Lingelbach S; Ramaswamy A; Hofbauer LC; Zielke A
    Endocrine; 2006 Aug; 30(1):129-38. PubMed ID: 17185801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human thyroid tumor cell lines derived from different tumor types present a common dedifferentiated phenotype.
    van Staveren WC; Solís DW; Delys L; Duprez L; Andry G; Franc B; Thomas G; Libert F; Dumont JE; Detours V; Maenhaut C
    Cancer Res; 2007 Sep; 67(17):8113-20. PubMed ID: 17804723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of miR-146b expression increases radioiodine-sensitivity in poorly differential thyroid carcinoma via positively regulating NIS expression.
    Li L; Lv B; Chen B; Guan M; Sun Y; Li H; Zhang B; Ding C; He S; Zeng Q
    Biochem Biophys Res Commun; 2015 Jul; 462(4):314-21. PubMed ID: 25960292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.